Carl Zeiss Meditec AG:Ad hoc: Ad hoc statement pursuant to Section 15 WpHG (Securities Trading Act)
(Thomson Reuters ONE) -
Carl Zeiss Meditec AG /
/
Ad hoc: Ad hoc statement pursuant to Section 15 WpHG (Securities Trading Act)
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Carl Zeiss Meditec expected to report revenue of approximately EUR 432m for the
first half of the current financial year
Jena/Germany 2 April 2012
Carl Zeiss Meditec AG [ISIN: DE0005313704) will report revenue of approximately
EUR 432m for the first half of the current financial year (1 October 2011 - 31
March 2012). This corresponds to an increase of about 15 % over the equivalent
period last year. Earnings before interest and tax are also expected to increase
compared with the previous year.
All the regions and strategic business units contributed to the gratifying
upturn in business. A key factor behind this significant increase in sales was
again the gratifying performance of the Microsurgery strategic business unit and
the dynamic growth in the Asia/Pacific region.
The final business figures will be announced in the 6 month report, scheduled
for publication on 15 May 2012.
Contact
Carl Zeiss Meditec AG, Henriette Meyer/Director Investor Relations, Göschwitzer
Str. 51-52, D-07745 Jena Phone +49 -3641 -220-106 Fax: +49-3641-220-117, E-Mail:
investors(at)meditec.zeiss.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Carl Zeiss Meditec AG via Thomson Reuters ONE
[HUG#1599311]
Unternehmensinformation / Kurzprofil:
Datum: 02.04.2012 - 11:27 Uhr
Sprache: Deutsch
News-ID 130783
Anzahl Zeichen: 2038
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carl Zeiss Meditec AG:Ad hoc: Ad hoc statement pursuant to Section 15 WpHG (Securities Trading Act)"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
